InvestorsHub Logo
icon url

caravon

08/13/13 2:17 PM

#165280 RE: DewDiligence #165278

NVS not bidding for ONXX



No wonder. The $130 price for ONXX is at least $2B over a reasonable price. But again, large biotech companies are hugely overpriced going into Obamacare where a price control will inevitable take place.
icon url

JJM760

08/13/13 2:19 PM

#165281 RE: DewDiligence #165278

Perfect! That frees up plenty of cash to buy Ariad when Epic renders Tasigna worthless.

<kidding> <mostly>